XML 145 R130.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segments of Business - Schedule Of Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Revenues                      
Total Revenues $ 51,628 $ 53,617 $ 52,061 $ 51,051 $ 48,713 $ 50,130 $ 49,957 $ 49,733 $ 208,357 $ 198,533 $ 190,884
Operating profit                      
Operating income                 762 7,109 3,545
Loss on Debt Extinguishment                 (122) 0 0
Interest Expense                 (283) (308) (353)
Income from Continuing Operations Before Income Taxes                 239 6,891 3,250
Depreciation and amortization                      
Total                 951 910 885
Expenditures for long-lived assets                      
Total                 405 404 488
United States                      
Revenues                      
Total Revenues                 169,943 164,428 158,255
Foreign                      
Revenues                      
Total Revenues                 38,414 34,105 32,629
Operating Segments                      
Revenues                      
Total Revenues                 208,357 198,533 190,884
Operating profit                      
Operating income                 1,208 7,576 4,072
Operating Segments | Distribution Solutions                      
Revenues                      
Total Revenues                 208,117 195,923 187,999
Operating profit                      
Operating income                 1,231 3,361 3,553
Depreciation and amortization                      
Total                 831 735 669
Expenditures for long-lived assets                      
Total                 306 276 306
Operating Segments | Distribution Solutions | Reportable Subsegments | North America pharmaceutical distribution and services                      
Revenues                      
Total Revenues                 174,186 164,832 158,469
Operating Segments | Distribution Solutions | Reportable Subsegments | International pharmaceutical distribution and services                      
Revenues                      
Total Revenues                 27,320 24,847 23,497
Operating Segments | Distribution Solutions | Reportable Subsegments | Medical-Surgical distribution and services                      
Revenues                      
Total Revenues                 6,611 6,244 6,033
Operating Segments | Technology Solutions                      
Revenues                      
Total Revenues                 240 2,610 2,885
Operating profit                      
Operating income                 (23) 4,215 519
Depreciation and amortization                      
Total                 9 65 107
Expenditures for long-lived assets                      
Total                 0 30 15
Segment Reconciling Items                      
Operating profit                      
Corporate Expenses, Net                 (564) (377) (469)
Corporate                      
Depreciation and amortization                      
Total                 111 110 109
Expenditures for long-lived assets                      
Total                 $ 99 $ 98 $ 167